Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.1 | - |
NAV | ₹11.65 | - |
Fund Started | 16 Oct 2023 | - |
Fund Size | ₹103.67 Cr | - |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.59% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 83.26% | - |
Cash | 16.74% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Supriya Lifescience Ltd. | 3.35% |
Eris Lifesciences Ltd. | 2.92% |
Crompton Greaves Consumer Electricals Ltd. | 2.83% |
Karur Vysya Bank Ltd. | 2.68% |
CMS Info Systems Ltd. | 2.62% |
EPL Ltd. | 2.58% |
Gujarat State Petronet Ltd. | 2.43% |
HDFC Bank Ltd. | 2.42% |
MPS Ltd. | 2.36% |
CSB Bank Ltd. | 2.33% |
Name | Chirag Mehta | - |
Start Date | 16 Oct 2023 | - |
Name
Start Date
Description | The Scheme seeks to generate capital appreciation by investing predominantly in Small Cap Stocks. There is no assurance that the investment objective of the scheme will be achieved. | - |
Launch Date | 16 Oct 2023 | - |
Description
Launch Date